Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Journal of the National Cancer Institute
|
August 5, 2011
The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells
Xiao-Feng Le, Weiqun Mao, Guangan He, et al.
Molecular Pharmaceutics
|
October 29, 2025
Profiling the Preclinical Pharmacokinetics and Biodistribution of a Platinum(IV)-Based Oxaliplatin Prodrug OxaliTEX and Their Significance to Antitumor Response
Guangan He, Gregory D Thiabaud, Kathryn A Shelton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 2012
Tissue platinum concentration and tumor response in non-small-cell lung cancer
Eric S Kim, J Jack Lee, Guangan He, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 22, 2020
Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor Immunity
Bangxing Hong, Valerie Chapa, Uksha Saini, et al.
Cancers
|
March 14, 2026
MicroRNA-625-3p Increases Chemosensitivity in Ovarian Cancer Cells Through Decreasing SSX2IP-Mediated Cisplatin Export in Extracellular Vesicles
Chi-Lam Au-Yeung, Tetsushi Tsuruga, Marina A Talor, et al.
Clinical Epigenetics
|
March 26, 2015
Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy
Apostolia M Tsimberidou, Rabih Said, Kirk Culotta, et al.
Ebiomedicine
|
January 19, 2019
PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis
Cristian Rodriguez-Aguayo, Emine Bayraktar, Cristina Ivan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 18, 2020
Oxaliplatin Pt(IV) prodrugs conjugated to gadolinium-texaphyrin as potential antitumor agents
Grégory Thiabaud, Guangan He, Sajal Sen, et al.
Neoplasia (New York, N.Y.)
|
May 2, 2013
Biologic effects of dopamine on tumor vasculature in ovarian carcinoma
Myrthala Moreno-Smith, Sun Joo Lee, Chunhua Lu, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Journal of the National Cancer Institute
|
August 5, 2011
The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells
Xiao-Feng Le, Weiqun Mao, Guangan He, et al.
Molecular Pharmaceutics
|
October 29, 2025
Profiling the Preclinical Pharmacokinetics and Biodistribution of a Platinum(IV)-Based Oxaliplatin Prodrug OxaliTEX and Their Significance to Antitumor Response
Guangan He, Gregory D Thiabaud, Kathryn A Shelton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 2012
Tissue platinum concentration and tumor response in non-small-cell lung cancer
Eric S Kim, J Jack Lee, Guangan He, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 22, 2020
Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor Immunity
Bangxing Hong, Valerie Chapa, Uksha Saini, et al.
Cancers
|
March 14, 2026
MicroRNA-625-3p Increases Chemosensitivity in Ovarian Cancer Cells Through Decreasing SSX2IP-Mediated Cisplatin Export in Extracellular Vesicles
Chi-Lam Au-Yeung, Tetsushi Tsuruga, Marina A Talor, et al.
Clinical Epigenetics
|
March 26, 2015
Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy
Apostolia M Tsimberidou, Rabih Said, Kirk Culotta, et al.
Ebiomedicine
|
January 19, 2019
PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis
Cristian Rodriguez-Aguayo, Emine Bayraktar, Cristina Ivan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 18, 2020
Oxaliplatin Pt(IV) prodrugs conjugated to gadolinium-texaphyrin as potential antitumor agents
Grégory Thiabaud, Guangan He, Sajal Sen, et al.
Neoplasia (New York, N.Y.)
|
May 2, 2013
Biologic effects of dopamine on tumor vasculature in ovarian carcinoma
Myrthala Moreno-Smith, Sun Joo Lee, Chunhua Lu, et al.
Page
of 2